IPSS-R very low/IPSS-R low/IPSS-R intermediate
Showing 26 - 50 of >10,000
Myelodysplastic Syndrome Trial in France, Germany, Spain (Lenalidomide, Placebo)
Active, not recruiting
- Myelodysplastic Syndrome
- Lenalidomide
- Placebo
-
Strasbourg, Bajo Rin, France
- +24 more
Nov 22, 2021
Lymphoma, Follicular, Lymphoma, Low-Grade, Lymphoma, Intermediate-Grade Trial in Munich (procedure, drug, other)
Active, not recruiting
- Lymphoma, Follicular
- +2 more
- FCM
- +3 more
-
Munich, GermanyGerman Low Grade Study Group (Glsg)
May 6, 2021
Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or
Terminated
- Myelodysplastic Syndrome
- +3 more
- rigosertib
- +2 more
-
La Jolla, California
- +157 more
Sep 22, 2022
MDS Trial in Worldwide (Magrolimab, Azacitidine, Placebo)
Active, not recruiting
- Myelodysplastic Syndromes
- Magrolimab
- +2 more
-
Birmingham, Alabama
- +168 more
Dec 7, 2022
REVLIMID® Treatment of IPSS Low- or Intermediate-1-risk
Recruiting
- Myelodysplastic Syndromes
- +2 more
-
Anyang, Korea, Republic of
- +12 more
Apr 6, 2021
Prostate Cancer Stage I Trial in Torino (Katty focal therapy)
Completed
- Prostate Cancer Stage I
- Katty focal therapy
-
Torino, TO, ItalyA.O.U. San Giovanni Battista Molinette
Jan 31, 2023
Anemia Trial in United States (Drawing admission labs from cord blood, Drawing admission labs from infant blood)
Completed
- Anemia
- Drawing admission labs from cord blood
- Drawing admission labs from infant blood
-
Honolulu, Hawaii
- +5 more
Aug 18, 2021
Very Low Birth Weight Infant Trial in Canada (Standard fortification, Target fortification, BUN adjustable fortification)
Recruiting
- Very Low Birth Weight Infant
- Standard fortification
- +2 more
-
Edmonton, Alberta, Canada
- +19 more
Apr 1, 2022
Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine,
Active, not recruiting
- Myelodysplastic Syndrome
- +2 more
-
Daphne, Alabama
- +241 more
Dec 23, 2022
MDS, Del(5Q), Anemia Trial in Italy (Luspatercept Injection [Reblozyl])
Recruiting
- Myelodysplastic Syndromes
- +3 more
- Luspatercept Injection [Reblozyl]
-
Alessandria, Italy
- +22 more
Jun 20, 2023
Very Low Birth Weight Infant (<1250g) Trial in Canada (Human milk-based fortifier, Bovine protein-based fortifier)
Completed
- Very Low Birth Weight Infant (<1250g)
- Human milk-based fortifier
- Bovine protein-based fortifier
-
Halifax, Nova Scotia, Canada
- +17 more
Nov 23, 2021
MDS (MDS) Trial in United States (Alvocidib Plus Decitabine (during dose escalation only) or Azacitidine)
Completed
- Myelodysplastic Syndromes (MDS)
- Alvocidib Plus Decitabine (during dose escalation only) or Azacitidine
-
Chicago, Illinois
- +11 more
Apr 4, 2022
Non-specific Low Back Pain Trial (Multimodal Exercises and Education delivered through tele rehabilitation, Selafcare)
Not yet recruiting
- Non-specific Low Back Pain
- Multimodal Exercises and Education delivered through tele rehabilitation
- Selafcare
- (no location specified)
Oct 15, 2023
Aplastic Anemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Houston (Anti-Thymocyte Globulin,
Recruiting
- Aplastic Anemia
- +3 more
- Anti-Thymocyte Globulin
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Dec 1, 2021
Urinary Tract Infection Trial in Taichung (Nettle and Cranberry complex capsules, Placebo(starch))
Not yet recruiting
- Urinary Tract Infection
- Nettle and Cranberry complex capsules
- Placebo(starch)
-
Taichung, TaiwanChung Shan Medical University Hospital
May 19, 2023
Philadelphia Negative Myeloproliferative Tumors Trial
Not yet recruiting
- Philadelphia Negative Myeloproliferative Neoplasms
- (no location specified)
Jun 5, 2022
Myelodysplastic Syndrome (MDS) Trial (FF-10501-01, Azacitidine)
Withdrawn
- Myelodysplastic Syndrome (MDS)
- (no location specified)
Jul 20, 2021
Prostate Cancer Trial in Québec (Low-Dose Rate Brachytherapy to the prostate using Iodine-125 seed implant, Stereotactic Body
Recruiting
- Prostate Cancer
- Low-Dose Rate Brachytherapy to the prostate using Iodine-125 seed implant
- Stereotactic Body Radiation Therapy to the prostate
-
Québec, CanadaCentre Intégré de Cancérologie, CHU de Québec-Université Laval
Sep 21, 2023
ACL Injury, ACL Sprain, ACL Tear Trial (Isoinertial training, Strength Training)
Not yet recruiting
- ACL Injury
- +4 more
- Isoinertial training
- Strength Training
- (no location specified)
Sep 25, 2023
MDS Patients Using Sequential Peripheral Blood Samples
Recruiting
- Myelodysplastic Syndromes
-
Badalona, Barcelona, SpainJosep Carreras Leukaemia Research Institute
Mar 8, 2022
Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (H3B-8800 (RVT-2001))
Recruiting
- Leukemia, Myeloid, Acute
- +2 more
- H3B-8800 (RVT-2001)
-
Stanford, California
- +26 more
Mar 23, 2022